LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_181523.2:c.1126G>A
PIK3R1
· NP_852664.1:p.(Gly376Arg)
· NM_181523.2
GRCh37: chr5:67589138 G>A
·
GRCh38: chr5:68293310 G>A
Gene:
PIK3R1
Transcript:
NM_181523.2
Final call
VUS
PM2 supporting
Variant details
Gene
PIK3R1
Transcript
NM_181523.2
Protein
NP_852664.1:p.(Gly376Arg)
gnomAD AF
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent from gnomAD v4.1, total allele frequency below the VCEP's 0.00000132 threshold.
2
Overall classification VUS: point total +1 under the Bayesian framework (Rule3: 0–5 points).
Final determination:
Under the PIK3R1 VCEP point-based framework, a total evidence score of 0-5 (Rule3) maps to Uncertain Significance; this variant scores +1 from PM2_Supporting alone, with no other criteria met.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: this is a missense substitution, and the PIK3R1 VCEP PVS1 rule covers only loss-of-function variants. |
cspec
|
| PS1 | Not assessed | Not assessed: no alternate-nucleotide variant producing the same p.(Gly376Arg) change with a pathogenic VCEP classification was identified. |
cspec
pm5_candidates
|
| PS2 | Not assessed | Not assessed: no parental genotypes, parentage confirmation, or family-history information was available to establish a de novo occurrence. |
cspec
|
| PS3 | Not assessed | Not assessed: no data showed this variant tested in the VCEP-approved functional assays (lipid/AKT kinase, protein binding, conformational dynamics). |
|
| PS4 | Not assessed | Not assessed: no germline immunodeficiency probands with this variant and evaluable phenotype data were available. |
cspec
clinvar
|
| PM1 | N/A | Not applicable: the PIK3R1 VCEP specification designates PM1 out of scope, with no hotspot-based moderate criterion for missense variants. |
cspec
|
| PM2 | Met | Met (Supporting): absent from gnomAD v4.1, total allele frequency below the VCEP's 0.00000132 threshold. |
cspec
gnomad_v4
|
| PM3 | N/A | Not applicable: the PIK3R1 VCEP limits PM3 to recessive disorders, and the curated disease context here is autosomal dominant. |
cspec
|
| PM4 | N/A | Not applicable: a single-nucleotide missense change alters one amino acid without changing protein length, so the in-frame-indel/stop-loss rule does not apply. |
cspec
|
| PM5 | Not assessed | Not assessed: no different-amino-acid change at codon 376 with a pathogenic VCEP classification was available to compare. |
cspec
pm5_candidates
|
| PM6 | N/A | Not applicable: the VCEP handles de novo evidence through PS2 instead, and no parental-testing data were available. |
cspec
|
| PP1 | Not assessed | Not assessed: no relatives' genotypes, phenotypes, or meioses were documented, so co-segregation could not be counted. |
cspec
|
| PP2 | N/A | Not applicable: the PIK3R1 VCEP specification designates PP2 out of scope for this gene. |
cspec
|
| PP3 | Not assessed | Not assessed: REVEL 0.778 clears the 0.644 threshold, but the required CADD score was unavailable, so the PP3 missense condition could not be confirmed. |
cspec
revel
spliceai
|
| PP4 | Not assessed | Not assessed: no individual with the germline PIK3R1-related phenotype was documented, so phenotype score and PIK3CD exclusion could not be evaluated. |
cspec
clinvar
|
| PP5 | Not assessed | Not assessed: no ClinVar expert-panel pathogenic or likely-pathogenic classification exists for this exact variant. |
clinvar
|
| BA1 | Not met | Not met: absent from gnomAD v4.1, below the VCEP's 0.00316 GrpMax allele-frequency threshold. |
cspec
gnomad_v4
|
| BS1 | Not met | Not met: absent from gnomAD v4.1, below the VCEP's 0.000316 GrpMax allele-frequency threshold. |
cspec
gnomad_v4
|
| BS2 | N/A | Not applicable: the PIK3R1 VCEP specification designates BS2 out of scope. |
cspec
|
| BS3 | Not assessed | Not assessed: no functional assay data specific to this variant were available, so a benign assay result could not be confirmed. |
|
| BS4 | Not assessed | Not assessed: no affected relatives reported as lacking this variant were documented, so non-segregation could not be assessed. |
cspec
|
| BP1 | N/A | Not applicable: the PIK3R1 VCEP specification designates BP1 out of scope. |
cspec
|
| BP2 | N/A | Not applicable: the PIK3R1 VCEP disallows BP2 because allelic mechanisms and combinatorial variant effects are not fully understood. |
cspec
|
| BP3 | N/A | Not applicable: the PIK3R1 VCEP specification marks BP3 out of scope for this gene. |
cspec
|
| BP4 | Not met | Not met: REVEL 0.778 far exceeds the ≤0.290 ceiling, so the BP4 missense condition fails outright. |
cspec
revel
|
| BP5 | Not assessed | Not assessed: no evidence showed this variant in an individual with an independently established alternative molecular cause. |
cspec
clinvar
|
| BP6 | Not assessed | Not assessed: no ClinVar expert-panel benign or likely-benign classification exists for this exact variant. |
clinvar
|
| BP7 | N/A | Not applicable: the VCEP's BP7 applies only to synonymous or intronic variants, not this missense change. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.